GNH USA

Europe — EMA

Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

GNH USA supplies Milgamma (Benfotiamine, Pyridoxine), a Vitamin B1 analogue and Vitamin B6 nutritional supplement for neuropathy and vitamin deficiency.

Request sourcing

1
Pack/s

What is Benfotiamine, Pyridoxine Hydrochloride?

Benfotiamine, the active ingredient in Milgamma, is a Vitamin B1 analogue presented as a nutritional supplement for oral use. It is combined with pyridoxine hydrochloride, a Vitamin B6 source, to support metabolic processes and nerve health in adults. GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Benfotiamine, Pyridoxine Hydrochloride used for?

Milgamma, containing benfotiamine and pyridoxine, is used to support conditions related to nerve function and vitamin B deficiencies. - Diabetic peripheral neuropathy: helps maintain nerve health and may alleviate sensory symptoms. - Alcohol‑induced neuropathy: provides vitamin B1 and B6 support to reduce nerve damage. - Vitamin B6 deficiency: restores normal pyridoxine levels for enzymatic reactions. - General nutritional support: contributes to overall metabolic function in individuals with increased vitamin needs.

What are the side effects of Benfotiamine, Pyridoxine Hydrochloride?

Milgamma is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: occasional cramps or bloating. - Headache: transient mild headache. - Skin rash: mild erythema or itching. - Dizziness: brief light‑headedness.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hepatic enzyme elevation: abnormal liver function tests. - Hematologic abnormalities: rare blood dyscrasias. - Severe hypersensitivity: swelling of face, lips, or throat.

What precautions apply to Benfotiamine, Pyridoxine Hydrochloride?

When considering Milgamma, take the following precautions. - Assess vitamin status: evaluate baseline B1/B6 levels before supplementation. - Monitor for allergies: discontinue if signs of hypersensitivity appear. - Renal or hepatic impairment: use with caution and under medical supervision. - Interaction with levodopa: pyridoxine may reduce levodopa efficacy; consult a physician. - Pregnancy and breastfeeding: discuss use with a healthcare professional before starting. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

What does Benfotiamine, Pyridoxine Hydrochloride interact with?

Milgamma may interact with certain medications; awareness of these interactions helps ensure safety.

Major Interactions (Avoid): - Levodopa: pyridoxine can diminish levodopa absorption and effectiveness. - High‑dose chemotherapy agents: excessive vitamin B6 may interfere with treatment efficacy.

Moderate Interactions (Monitor Closely): - Antidiabetic drugs: benfotiamine may influence glucose control, requiring monitoring. - Diuretics: increased urinary excretion may affect vitamin levels. - Anticonvulsants: pyridoxine can alter metabolism of some seizure medications.

Frequently asked questions

What is Milgamma used for?+
Milgamma is a nutritional supplement that combines benfotiamine (a Vitamin B1 analogue) and pyridoxine hydrochloride (Vitamin B6). It is commonly used to support nerve health in conditions such as diabetic or alcohol‑related neuropathy and to address vitamin B6 deficiency or general metabolic needs.
How does benfotiamine work in the body?+
Benfotiamine is a lipid‑soluble form of thiamine that readily enters cells and is converted to thiamine diphosphate. This co‑factor participates in glucose metabolism, helps reduce the formation of harmful advanced glycation end‑products, and supports the function of peripheral nerves.
What is the usual dose of Milgamma?+
The appropriate dose of Milgamma is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, and overall health. Patients should follow the specific instructions provided by their doctor or pharmacist.
Is Milgamma safe during pregnancy or breastfeeding?+
Safety data for Milgamma in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before using the product.
How do I order Milgamma from GNH USA?+
To order Milgamma, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Milgamma compare with other vitamin B supplements?+
Milgamma combines benfotiamine, a highly bioavailable thiamine derivative, with pyridoxine hydrochloride, offering both Vitamin B1 and B6 in one formulation. Compared with standard thiamine or pyridoxine tablets, benfotiamine provides better cellular uptake, which may enhance metabolic and neuroprotective effects.
What are the storage requirements for Milgamma?+
Milgamma should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.
How is Milgamma administered?+
Milgamma is taken orally, usually with water. The exact timing (e.g., with meals or on an empty stomach) should follow the prescribing clinician’s guidance to optimize absorption and minimize gastrointestinal discomfort.
What are the most serious risks associated with Milgamma?+
Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, significant liver enzyme elevations, and hematologic abnormalities. Any signs of these conditions require immediate medical attention.
Who should not use Milgamma?+
Individuals with known hypersensitivity to benfotiamine, pyridoxine, or any excipients in the formulation should avoid Milgamma. Patients on levodopa therapy should consult a physician before use, and those with severe renal or hepatic impairment should be evaluated by a healthcare professional.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Benfotiamine, Pyridoxine Hydrochloride
Route
Oral Use
Manufacturer
Wörwag Pharma Gmbh & Co. Kg
Origin
EU

Related products